A Study of Clinical Practice and Real-world Care of Patients Treated With mTOR, PI3K, and MEK Inhibitors for Extracranial Vascular Anomalies
Clinical trial NCT07767877 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07767877
- Sponsor
- Novartis Pharmaceuticals
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-08-31
- Primary completion
- 2027-10-30
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.